Cost-effectiveness of aspirin for the primary prevention of coronary heart disease

被引：0
|
作者：
Rodondi, Nicolas
Moran, Andrew
Coxson, Pamela G.
Lightwood, James
Williams, Lawrence W.
Cornuz, Jacques
Goldman, Lee
机构：
[1] Univ Lausanne, CH-1015 Lausanne, Switzerland
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
CIRCULATION | 2006年 / 114卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：827 / 827
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ASPIRIN IN SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    GASPOZ, JM
    GOLDMAN, P
    WILLIAMS, L
    WEINSTEIN, M
    GOLDMAN, L
    [J]. CIRCULATION, 1995, 92 (08) : 219 - 219
  • [2] Comparative cost-effectiveness of interventions for the primary prevention of coronary heart disease
    Lim, SS
    Vos, TE
    Begg, S
    Liew, D
    Peeters, A
    McNeil, JJ
    [J]. CIRCULATION, 2002, 106 (19) : 758 - 759
  • [3] Cost-effectiveness of statins for primary prevention of coronary heart disease in Japan
    Ikeda, Shunya
    Kobayashi, Makoto
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 : S225 - S226
  • [4] Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, costs and cost-effectiveness
    Ho, WK
    Hankey, GJ
    Eikelboom, JW
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 493 - 503
  • [5] Cost-effectiveness of sitostanols for the primary prevention of coronary heart disease in the Australian population
    Ashton, EL
    Lim, S
    McNeil, JJ
    Vos, T
    [J]. CIRCULATION, 2002, 106 (19) : 742 - 742
  • [6] Cost-effectiveness analysis for statin therapies in the primary prevention of coronary heart disease in Italy
    Berto, P
    Munro, V
    Gaddi, A
    Negrini, C
    Hutton, J
    Mast, O
    [J]. CLINICAL DRUG INVESTIGATION, 2000, 20 (02) : 109 - 121
  • [7] Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy
    Patrizia Berto
    Vicky Munro
    Antonio Gaddi
    Cristina Negrini
    John Hutton
    Oliver Mast
    [J]. Clinical Drug Investigation, 2000, 20 : 109 - 121
  • [8] A concise review of the cost-effectiveness of coronary heart disease prevention
    Brown, AID
    Garber, AM
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (01) : 279 - +
  • [9] Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care
    Turner, D. A.
    Paul, S.
    Stone, M. A.
    Juarez-Garcia, A.
    Squire, I.
    Khunti, K.
    [J]. HEART, 2008, 94 (12) : 1601 - 1606
  • [10] Cost-effectiveness of Maintaining Daily Intake of Oat β-Glucan for Coronary Heart Disease Primary Prevention
    Earnshaw, Stephanie R.
    McDade, Cheryl L.
    Chu, YiFang
    Fleige, Lisa E.
    Sievenpiper, John L.
    [J]. CLINICAL THERAPEUTICS, 2017, 39 (04) : 804 - 818
12345